FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...

A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...

The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.